Experiences and unmet needs in non-alcoholic steatohepatitis (NASH): Insights from patients and patient caregivers

Jeff McIntyre¹, Naim Alkhouri², Villum Wittrup-Jensen³, Hans-Jacob Randskov³, Emmanuel Tsochatzis⁴, Teresa Casanovas^5,6, Ramy Younes³, Jörn M. Schattenberg⁷

¹Global Liver Institute, Washington, DC, USA; ²Arizona Liver Health, Phoenix, AZ, USA; ³Boehringer Ingelheim International GmbH, Ingelheim, Germany; ⁴UCL Institute for Liver and Digestive Health, London, UK; ⁵Asociación Catalana de Pacientes Hepáticos (ASSCAT), Barcelona, Spain; ⁶European Liver Patients’ Association (ELPA), Brussels, Belgium; ⁷Metabolic Liver Research Program, I. Department of Medicine, University Medical Center Mainz, Mainz, Germany